Related Experiment Video
Updated: Dec 21, 2025

Accelerated Type 1 Diabetes Induction in Mice by Adoptive Transfer of Diabetogenic CD4+ T Cells
Published on: May 6, 2013
PPARs and the Development of Type 1 Diabetes
Laurits J Holm1, Mia Øgaard Mønsted1, Martin Haupt-Jorgensen1
1The Bartholin Institute, Department of Pathology, Copenhagen University Hospital, Denmark.
Peroxisome proliferator-activated receptors (PPARs) influence glucose and lipid metabolism, impacting pancreatic beta cells and immune cells. PPAR agonists show promise in preventing type 1 diabetes by targeting both systems.
Area of Science:
- Endocrinology
- Immunology
- Metabolic Research
Background:
- Peroxisome proliferator-activated receptors (PPARs) are crucial transcription factors regulating glucose and lipid metabolism.
- PPARs are expressed in pancreatic beta cells and immune cells, influencing insulin secretion and T cell differentiation.
- PPAR agonists have demonstrated efficacy in preventing type 1 diabetes in non-obese diabetic (NOD) mouse models.
Purpose of the Study:
- To review the multifaceted role of PPARs in immune responses.
- To examine the involvement of PPARs in beta cell biology.
- To explore the therapeutic potential of PPARs for type 1 diabetes (T1D) treatment.
Main Methods:
- Literature review of studies on PPARs, immune cells, and beta cells.
- Analysis of data from non-obese diabetic (NOD) mouse models.
- Examination of the regulatory functions of PPARs in metabolic and immune pathways.
Main Results:
- PPARs play a significant role in modulating immune cell function and T cell differentiation.
- PPARs are integral to maintaining beta cell function and insulin secretion.
- PPAR agonists have shown protective effects against T1D development in preclinical models.
Conclusions:
- PPARs represent a promising therapeutic target for type 1 diabetes.
- Targeting PPARs offers a dual approach, addressing both pancreatic and immune system aspects of T1D.
- Further research into PPAR agonists could lead to novel T1D treatments.
More Related Videos
Related Concept Videos
Diabetes Mellitus: Overview and Type I Subtype
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Diabetes Mellitus: Type 2 and Gestational
Pathophysiology of Diabetes
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
Diabetes: Symptoms, Diagnosis, and Complications
Carbohydrate Metabolism
Starch accounts for approximately 60% of the carbohydrates consumed by humans. Since amylase enzymes cannot function in the stomach's acidic environment, starch can only be digested in the mouth and small intestine. Simple sugars are found naturally in milk and fruits in...
Insulin: Biosynthesis, Chemistry, and Preparation
Damage or functional impairment of β-cells inhibits insulin production, leading to diabetes. Diabetes treatment...

